The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene  by Lin, Ling et al.
Cell, Vol. 98, 365±376, August 6, 1999, Copyright 1999 by Cell Press
The Sleep Disorder Canine Narcolepsy
Is Caused by a Mutation in the Hypocretin
(Orexin) Receptor 2 Gene
rhythmicity in Drosophila and/or mammals (Huang et
al., 1993; Sehgal et al., 1994; King et al., 1997; Shearman
et al., 1997; Sun et al., 1997). Protein±protein interactions
within the PAS domain and transcription±translation
feedback loops have been established to be primary
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One pathway to this understanding is the study of the
sleep disorder narcolepsy. Narcolepsy is a disabling
neurological disorder that affects more than 1 in 2,000Summary
Americans (Mignot, 1998). The disorder is characterized
by daytime sleepiness, sleep fragmentation, and symp-Narcolepsy is a disabling sleep disorder affecting hu-
toms of abnormal REM sleep, such as cataplexy, sleepmans and animals. It is characterized by daytime
paralysis, and hypnagogic hallucinations (Aldrich, 1993;sleepiness, cataplexy, and striking transitions from
Nishino and Mignot, 1997; Aldrich, 1998). It is the onlywakefulness into rapid eye movement (REM) sleep. In
known neurological disorder that specifically affects thethis study, we used positional cloning to identify an
generation and organization of sleep. Narcolepsy hasautosomal recessive mutation responsible for this
also been reported to occur in animals and has beensleep disorder in a well-established canine model. We
most intensively studied in canines (Foutz et al., 1979;have determined that canine narcolepsy is caused by
Baker and Dement, 1985; Nishino and Mignot, 1997;disruption of the hypocretin (orexin) receptor 2 gene
Cederberg et al., 1998). A large number of physiological(Hcrtr2). This result identifies hypocretins as major
and pharmacological studies performed over a 20 yearsleep-modulating neurotransmitters and opens novel
period have demonstrated a close similarity betweenpotential therapeutic approaches for narcoleptic pa-
human and canine narcolepsy (Baker and Dement, 1985;tients.
Nishino and Mignot, 1997). Strikingly, humans and canines
with narcolepsy exhibit cataplexy, sudden episodes ofIntroduction
muscle weakness akin to REM sleep±associated atonia
that are triggered primarily by positive emotions (Foutz et
Sleep is a vital behavior of unknown function that con-
al., 1979; Baker and Dement, 1985; Nishino and Mignot,
sumes one-third of any given human life (Dement, 1994). 1997).
Electrophysiological studies have shown that sleep is a Although familial cases of narcolepsy have been re-
heterogenous state most classically separated into ported, most human occurrences are sporadic, and the
rapid eye movement (REM) sleep and non-REM sleep disorder is generally believed to be multigenic and envi-
(Dement, 1994). REM sleep is characterized by vivid ronmentally influenced (Honda and Matsuki, 1990; Mig-
dreaming, muscle atonia, desynchronized electroen- not, 1998). One predisposing genetic factor is a specific
cephalogram (EEG) activity, and REMs. Non-REM sleep HLA-DQ allele, HLA-DQB1*0602 (Matsuki et al., 1992;
is characterized by synchronized EEG activity, partial Mignot et al., 1994a; Mignot, 1998). Because of the tight
muscle relaxation, and less frequent dreaming menta- HLA association, the disorder in humans has been sug-
tion (Dement, 1994). REM and non-REM sleep are indis- gested to be autoimmune in nature; however, all at-
pensable to survival; both REM and total sleep depriva- tempts to verify this hypothesis have failed (Mignot et
tion are lethal in mammals (Rechtschaffen et al., 1983; al., 1995). In Doberman pinschers, the disorder is trans-
Kushida et al., 1989). Independent of this organization mitted as a single autosomal recessive trait with full
in REM and non-REM sleep, the propensity to sleep or penetrance, canarc-1 (Foutz et al., 1979; Baker and De-
stay awake is regulated by homeostatic (sleep debt± ment, 1985). To unravel the cause of this unique sleep
dependent) and circadian (clock-dependent) processes disorder, we undertook the positional cloning of the
(BorbeÂ ly, 1994). Circadian processes are believed to be canine narcolepsy gene. This project led us to identify
primarily generated at the genetic level within the supra- a mutation in the gene encoding the receptor for a novel
chiasmatic nucleus of the hypothalamus (Klein et al., neuropeptide, the hypocretin (orexin) receptor 2 (Hcrtr2),
1991; Moore and Silver, 1998). Mutations in selected as the cause of canine narcolepsy.
genes of the basic-helix-loop-helix (bHLH)-PAS domain
protein family, such as Clock, per, and cycle (BMAL1) or Results and Discussion
timeless, have been shown to selectively alter circadian
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retrievers and Doberman pinschers (Foutz et al., 1979).
A large number of backcrosses were generated in the
late 1980s in preparation for a linkage study using ran-
domly distributed markers and a candidate gene ap-
proach (Cederberg et al., 1998). Using this approach,
genetic linkage between canarc-1 and the canine major
histocompatibility complex was excluded (Mignot et al.,
1991). A tightly linked marker was identified using a
human m switch immunoglobulin variable heavy chain
probe (Mignot et al., 1991). This initial m switch±like link-
age marker was cloned using a HaeIII size-selected li-
brary (Mignot et al., 1994b). Sequencing of the fragment
only revealed a GC-rich repetitive sequence with high
homology to the human m switch locus. Further cloning
and sequencing studies using a SauIIIA1 partially di-
gested canine genomic phage library failed to identify
a neighboring immunoglobulin gene constant region
(Mignot et al., 1994b). This result suggested that the m
switch±like sequence was a cross-reacting repeat se-
quence of unknown significance rather than a genuine
immunoglobulin switch segment.
Chromosome walking using phage and cosmid librar-
ies was difficult because of the small sizes of inserts in
available libraries. We therefore decided to build a large
Figure 1. Two-Color Chromosomal FISH Showing Chromosomalinsert bacterial artificial chromosome (BAC) canine ge-
Colocalization of DLA and Myo6 on CFA12nomic library for this purpose (Li et al., 1999). The large
Note that dog autosomes are all acrocentric. DNA from the DLAinsert canine genomic BAC library was built using EcoRI
locus was labeled with biotin and detected with avidin FITC (green);
partially digested DNA fragments from a Doberman DNA from a canine BAC clone containing the m switch±like marker
pinscher. An animal born in one of our backcross litters and the Myo6 gene was labeled with digoxigenin and detected with
and heterozygous for canarc-1 was selected to build anti-digRhodamine (red) as described in Li et al. (1999). Note that
although the published localization of DLA is the telomere of CFA12the library. Having both the control and narcolepsy hap-
(Dutra et al., 1996), our result demonstrates a localization of DLAlotypes in separate BAC clones would allow us to iden-
to the centromere of CFA12.tify all possible disease-associated polymorphisms, and
thus the mutation. Approximately 166,000 clones were
al., 1999). Both DLA (dog leukocyte antigen), the caninegridded on nine high-density hybridization filters. Insert
equivalent of HLA (6p21), and BAC clones from our con-analysis of randomly selected clones indicated a mean
tig were found to be on canine chromosome CFA12 butinsert size of 155 kb and predicted 8.1-fold coverage of
at a very large genomic distance (.30 Mb) (Figure 1).the canine genome (Li et al., 1999). A 1.8 Megabase (Mb)
This caused us to suspect a large region of conservedcontig (77 BAC clones) was built in the region in an
synteny between human chromosome 6 and canineattempt to flank the canarc-1 gene. BAC clones con-
chromosome 12. This large region of conserved syntenytaining our m switch±like marker were isolated, and chro-
has been reported by other investigators (dog chromo-mosome walking was initiated from the ends. Microsat-
some 12 is also called U10 based on radiation hybridellite markers were developed in the contig, and 11
data) (Wakefield and Graves, 1996; Priat et al., 1998;polymorphic markers were typed in all informative ani-
Neff et al., 1999; Ryder et al., 1999).mals. (GAAA)n repeats (rather than most typically used
We used homology mapping experiments to facilitate(CA)n repeats) were found to be the most informative
identification of our susceptibility region. Human ex-repeat markers in canines as previously reported by Dr.
pressed sequence tag clones (ESTs) known to map aOstrander's group (Ostrander et al., 1995; Francisco et
few centimorgans distal and proximal to Myo6 wereal., 1996). All informative animals, whether Dobermans
obtained and used as hybridization probes on the canineor Labradors, were concordant for all the (CA)n and
BAC library filters. Positive clones were analyzed using(GAAA)n repeat markers developed in this contig. The
absence of any recombination events in this interval two-color FISH on dog metaphase spreads to screen
made it impossible to determine the location of canarc-1 for clones mapping to this portion of CFA12. This novel
in relation to our contig. strategy successfully identified approximately 150 ca-
nine BAC clones that were shown to contain the canine
equivalents of their corresponding human ESTs throughHomology Mapping Experiments between Human
Chromosome 6 and Canine Chromosome 12 hybridization and sequence analysis of plasmid sub-
clones (data not shown). Minilibraries from these clonesBAC end sequence data obtained through chromosome
walks was analyzed with BLAST against appropriate were generated to develop dinucleotide and tetranucle-
otide polymorphic markers, which were typed in ourGenBank databases. We identified a BAC end sequence
with high homology to Myo6, a gene located on the long canine crosses and unrelated narcoleptic dog founders.
This process was successfully repeated using all avail-arm of human chromosome 6 (6q12). A protocol for
sequential G banding and canine chromosomal fluores- able single-copy ESTs mapping within the region in hu-
mans until the canine narcolepsy critical region wascence in situ hybridization (FISH) was established (Li et
Narcolepsy and Hypocretin Receptor 2
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Figure 2. Overview of the Region Containing the Canine Narcolepsy Gene
Human and canine chromosomal regions of conserved synteny are displayed. Human ESTs are displayed on the human map in the top panel.
Physical distances in human were estimated by mapping the corresponding clones on the Stanford G3 radiation hybrid panel and using a
roughly estimated correspondence of 26 kb/cR. These EST clones were used as probes to isolate 154 cross-hybridizing BAC clones that
were verified by FISH to be within the canine region of conserved synteny. Chromosome walking was also performed from these locations,
thus resulting in the physical cloning of almost the entire genomic segment. More than 100 polymorphic microsatellite markers were isolated
from these clones and tested in narcoleptic and control canines. A total of 77 informative backcross Dobermans, 23 informative backcross
Labradors, and 5 informative Dachshund animals were tested. Twenty-five animals belonging to a New Jersey breeder pedigree (7 affected)
were also genotyped. Key recombinant animals are listed in the center of the Figure. The canine narcolepsy critical region is labeled in red.
The total LOD score in this subsegment is 32.1 at 0% recombination (n 5 105 animals) (Ott, 1991).
flanked (the more precise map position of several ESTs in other breeds. A maximum LOD score of 2.0 at 0%
recombination (p 5 0.01) was obtained in this litter forwas first estimated using the Stanford G3 radiation hy-
brid panel in several cases). Chromosome walking by the region immediately proximal to and including the
Hcrtr2 locus (all animals concordant). This putativefilter hybridization was also performed until the region
was almost entirely physically cloned (Figure 2). canarc-1-positive Dachshund pedigree includes a re-
combinant asymptomatic animal ªFritzº (Figure 2). TheBackcross breeding was continued in parallel with the
physical cloning effort. A Doberman litter born in our second pedigree (from New Jersey) is a very large Do-
berman breeder pedigree with seven affected animals.colony yielded our first narcolepsy/m switch±like marker
recombinant animal, which mapped the region proximal One of the affected animals was donated to the colony
and shown to be canarc-1 positive by breeding. In thisto the Prim2A locus (ªDC,º see Figure 2). This finding,
together with the observation of a crossover immedi- pedigree, all narcoleptic animals are identical by de-
scent in a region flanked proximally by EST 250618ately distal to EST 858129 (ªRingo,º Figure 2), reduced
the narcolepsy susceptibility interval to an estimated 4 (Jayde and Tasha, Figure 2). These findings allowed us
to narrow down the canine narcolepsy susceptibilityMb region (EST 858129 to Prim2A in Figure 2) in a total
of 100 informative backcross animals. Two pedigrees region to a subsegment of approximately 800 kb flanked
by EST 250618 and Hcrtr2.identified in outside breeder colonies were used to fur-
ther reduce the segment. The first pedigree (from New The distance between the initial linkage marker and
the critical region corresponds to a 10 cM distance onYork) is a familial narcolepsy Dachshund litter with three
affected and two unaffected animals. Linkage with the the human map (Figure 2) within an extensive region of
conserved synteny. However, the canine genetic dis-canarc-1 locus was considered likely in this litter, con-
sidering previously established linkage of this region tance estimated from our breeding studies indicates
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Figure 3. BAC Clone Contig Covering the 800 kb Segment Known to Contain canarc-1
The BAC clone sizes are drawn to scale. Selected polymorphic microsatellite markers are indicated by dotted lines. STSs for which locations
were not strictly constrained were spaced at roughly equidistant intervals between constrained markers. The canine narcolepsy gene critical
region is flanked by marker 26-12 (immediately distal to EST 250618) and marker 530-5 (immediately distal to EST 416643). All BAC clones
were genotyped with available informative markers to determine canarc-1 associated status. Narcolepsy/control segments are labeled in red
and green, respectively. Unclassified clones are shown in gray.
that the distance is 1 cM (only one recombinant animal, a G protein±coupled receptor with high affinity for the
hypocretin neuropeptides. The hypocretins (orexins)ªDC,º over 100 backcross animals). We suspect the re-
gion syntenic to the human chromosome centromere have primarily been implicated in the regulation of feed-
may have repressed recombination for an unknown rea- ing (De Lecea et al., 1998), but the broad neuroanatomi-
son. A map of the region as currently characterized is cal projections for hypocretin neurons (Peyron et al.,
depicted in Figure 2. The EST 858129 to Prim2A segment 1998; Nambu et al., 1999; van den Pol, 1999) and corre-
is approximately 4 Mb in humans (Figure 2) as estimated sponding receptor distribution (Trivedi et al., 1998) for
through radiation hybrid data (3 cM on the human map). this system suggest other possible functions (Peyron et
Interphase and metaphase FISH data in canines suggest al., 1998). To explore the possibility of an involvement of
the region is approximately of the same physical size in Hcrtr2 in the etiology of canine narcolepsy, BAC clones
canines (data not shown). A small gap (estimated at 400 containing either the canarc-1 or the wild-type-associ-
kb, based on the human radiation hybrid data, canine ated haplotypes were identified using previously identi-
clone contig size, and canine FISH data) remains in the fied polymorphic markers (see Figure 3). Narcolepsy and
contig, between Hcrtr2 and the procollagen a2 IV gene control allele±associated BAC clones were digested
(Figure 2). The precise location of the canine narcolepsy with four enzymes (HindIII, BglII, TaqI, and MspI), South-
gene is between EST 250618 and a region immediately ern blotted, and probed with a human HCRTR2 EST
distal to Hcrtr2 between markers 26-12 and 530-5 (Fig- probe. A clear restriction fragment length polymorphism
ure 3). The estimated overall LOD score in the critical (RFLP) pattern was observed with three of the four en-
region is 32.1 at 0% recombination (n 5 105 animals) zymes (BglII, TaqI, and MspI), suggesting a possible
(Ott, 1991). Twenty-five dogs born in the New Jersey genomic alteration in the vicinity of or within the canine
breeder colony are not included in the calculation due Hcrtr2 gene (Figure 4).
to inbreeding loops, missing animals, and the difficulty in
establishing precise family relationships in some cases.
Canine Narcolepsy Is Caused by a Mutation
in the Hcrtr2 GeneIdentification of an RFLP in the Vicinity
Degenerate consensus primers were designed basedof the Hcrtr2 Gene
on the 59 and 39 sequences of the published human andOnly one previously identified gene, Hcrtr2, was known
to reside within the critical region. This gene encodes rat Hcrtr2 cDNAs. cDNAs were prepared from the brains
Narcolepsy and Hypocretin Receptor 2
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boundary sequences of the locus in control and mutant
alleles. The 116 bp deletion in the transcript corresponds
to the fourth exon (Figure 6). Genomic sequencing of
the intron±exon boundary immediately preceding this
intron indicated that a 226 bp canine short interspersed
nucleotide element (SINE) (Minnick et al., 1992; Coltman
and Wright, 1994) was inserted 35 bp upstream of the
59 splice site of the fourth encoded exon (Figure 7).
This insertion falls within the 59 flanking intronic region
needed for pre-mRNA lariat formation and proper splic-
ing. The efficiency of pre-mRNA splicing is strongly af-
fected by alterations of the site within the intron that
binds to the U2 small nuclear ribonucleoprotein. This
region of complementarity includes the branchpoint se-
quence (BPS) at the site of lariat formation (Reed and
Maniatis, 1985, 1988). In mammals the BPS is a poorly
conserved element that conforms to a very loose con-
sensus sequence (PyXPyTPuAPy) in which the adenine
residue is of primary importance. The BPS is typicallyFigure 4. Autoradiograms Showing Alternate RFLP Alleles Associ-
located between 18 and 40 nucleotides upstream ofated with the Control versus Narcolepsy-Associated BAC Clones
the 39 splice junction, but this position may also varyWhen Hybridized with an HCRTR2 Probe
considerably. Despite the loose constraints on the con-Overlapping BAC clones (50A17, 337K2, 97F24, and 28L10) con-
sensus sequence and relative position of the BPS, alter-taining the canine homolog of the Hcrtr2 gene were digested with
restriction endonucleases TaqI, BglII, MspI, and HindIII, electropho- ations in the sequence may nearly abolish splicing (Reed
resed, transferred to nylon membrane, and hybridized with the IM- and Maniatis, 1985, 1988). The SINE insertion may thus
AGE clone 416643 (HCRTR2) probe. Haplotypes of BAC clones were have moved the functioning branchpoint sequence be-
previously identified by polymorphic markers. HindIII digest showed yond the acceptable range for efficient splicing (Figure
no restriction length polymorphism (data not shown).
7). PCR primers were designed in the immediate flanking
area, and PCR analysis was performed in control and
of four control and four narcoleptic Dobermans born in canarc-1-positive narcoleptic dogs of three breeds
our colony. Amplified products from the cDNA of narco- (Dobermans, Labradors, and Dachshunds). We identi-
leptic dogs significantly differed in size from the prod- fied the same SINE insertion in all 17 narcoleptic Dober-
ucts of the controls (1.5 versus 1.6 kb). This finding mans tested, including 6 dogs not known to be related
suggested a deletion in the transcripts of narcoleptic by descent by at least four generations but likely to be
animals (Figure 5A). Sequence analysis of the RT±PCR identical by descent as a result of a founder effect. The
product in narcoleptic and control animals indicated a SINE insertion was not found in the 36 control dogs
116 bp deletion, a result also confirmed by nested PCR tested, including 14 Dobermans, 13 Labradors, and 9
experiments on cDNA templates (data not shown). PCR Dachshunds (Figure 5B). Based on this result and the
primers scattered throughout the entire coding se- associated cDNA analysis, we conclude that the SINE
quence were used to directly sequence the correspond- insertion mutation is the cause of narcolepsy in Dober-
ing BAC clones representing both control and narcolep- mans. Similar retrotransposon insertion mutations have
been reported to cause human disease (see Kazazian,tic haplotypes. This allowed us to determine exon±intron
Figure 5. PCR Amplification Studies of the
Hcrtr2 Locus in Narcoleptic and Control Dogs
(A) Amplification of Hcrtr2 cDNA from control
and narcoleptic Doberman Pinschers. PCR
primers were designed in the 59 and 39 un-
translated regions of the Hcrtr2 gene (exon 1
and exon 7). The amplification product from
the control dog (lane 1) is the expected 1.6
kb size, whereas the product from the narco-
leptic dog (lane 2) is 1.5 kb. Forward PCR
primer, 5-2 (59GCTGCAGCCTCCAGGGCCG
GGTCCCTAGTTC 39); reverse primer, 3-2
(59ATCCCTGTCATATGAATGAATGTTCTAC
CAGTTTT 39).
(B) Amplification of narcoleptic and wild-type
Doberman Pinscher genomic DNA with PCR primers flanking the SINE insertion. PCR primers designed to flank the SINE insertion site produce
a 419 bp amplification product from DNA of wild-type dogs and a 645 bp product from narcoleptic Doberman Pinscher DNA. Products of
both sizes are amplified from the DNA of Dobermans known to be carriers of narcolepsy, and they also display prominent heteroduplex bands.
Lanes 1 and 2, wild-type Dobermans (Alex and Paris); lanes 3 and 4, narcoleptic Dobermans (Tasha and Cleopatra); lanes 5 and 6, heterozygous
carrier Dobermans (Grumpy and Bob). Forward primer w554-65seqF (59GGGAGGAACAGAAGGAGAGAATTT39) located in intronic sequence
upstream of the insertion. Reverse primer R4/7-6R(110) (59ATAGTTGTTAATGTGTACTTTAAGGC39) located in intronic sequence downstream
of exon 4.
(C) Amplification of narcoleptic and wild-type Labrador retriever Hcrtr2 cDNAs. Forward primer F6 59AGCGCTGT(G/C)GC(G/T)GCTGA(A/
G)ATAAAGCAGATC39 and reverse primer 3-2 were used. The amplification product from the control dog (lane 1) is the expected 501 bp size,
whereas the product from the narcoleptic dog (lane 2) is 379 bp.
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Figure 6. Deduced Amino Acid Sequences of
Hcrtr2 in Wild-Type Dog, Human, Rat, and
Narcoleptic Dogs
Amino acid residues that are not identical in
at least two sequences are boxed. Putative
transmembrane (TM) domains are marked
above the aligned sequences. Arrows indi-
cate exon/intron boundaries in the gene
structure of the dog. Sequence analysis of
RT±PCR products revealed that exon 4 (con-
tinuous line between arrowheads) and exon
6 (dotted line between arrowheads) are miss-
ing in RNA transcripts of narcoleptic Dober-
man pinschers (narc/Dob.) and Labrador re-
trievers (narc/Lab.), respectively. In both cases,
the deleted exon results in a frameshift and
the creation of a premature stop codon. The
full-length nucleotide sequences of the ca-
nine Hcrtr2 cDNA can be retrieved from Gen-
Bank under accession number AF164626.
1999 and the human gene mutation database http:// dogs (11 Labradors, 10 Dobermans, and 3 Dachshunds)
and 11 non-Labrador narcoleptic dogs (10 Dobermanswww.uwcm.ac.uk/awcm/mg/hgmd0.html).
The SINE insertion was not observed in canarc- and 1 Dachshund). The consensus position for the 15
nucleotide is G (84%), and an A in this position is rarely1-positive animals from other breeds (three Labrador
retrievers and one Dachshund; data not shown). This observed (Shapiro and Senapathy, 1987; Krawczak et
al., 1992). A G to A transition reduces the likelihoodled us to suspect that other mutations in the Hcrtr2 gene
might be involved in these cases. RT±PCR analysis was functional score for the 8 nucleotide splicing consensus
sequence from 88.4% to 74.8% (Shapiro and Senapathy,performed using cDNAs prepared from the brains of two
control and two narcoleptic Labrador retrievers born in 1987). Mutations in this position have been shown to
produce 100% exon skipping (Krawczak et al., 1992;our colony. Dachshund cDNA samples were not studied
because no brain samples were available. A shorter PCR McGrory and Cole, 1999; Teraoka et al., 1999).
The Hcrtr2 transcripts produced in narcoleptic ani-product was observed in narcoleptic versus control Lab-
rador retrievers (Figure 5C). Sequencing indicated a de- mals are grossly abnormal mRNA molecules. In Dober-
man pinschers, the mRNA potentially encodes a proteinletion of exon 6 (122 bp) in the narcolepsy-associated
cDNA. Analysis of the intron±exon boundaries and se- with 38 amino acids deleted within the fifth transmem-
brane domain followed by a frameshift and a prematurequencing of exon 6 revealed a G to A transition in the
59 splice junction consensus sequence (position 15, stop codon at position 932 in the encoded RNA. The C
terminus of the protein encoded by narcoleptic Labradorsexon 6±intron 6) in genomic DNA of narcoleptic Labrador
retrievers (Figure 7). This G to A transition was not ob- is also truncated and does not include a seventh trans-
membrane domain. These changes most likely disruptserved in the corresponding sequences of 24 control
Narcolepsy and Hypocretin Receptor 2
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Figure 7. Genomic Organization of the Canine Hcrtr2 Locus, which Is Encoded by Seven Exons
In transcripts from narcoleptic Doberman pinschers, exon 3 is spliced directly to exon 5, omitting exon 4 (narc. Dob. versus wild type). The
genomic DNA of narcoleptic Dobermans contains an 226 bp insertion corresponding to a common canine SINE repeat element (shown in
red) located 35 bp upstream of exon 4. The insertion of the SINE displaces a putative lariat branchpoint sequence (BPS, shown in green)
located at position 240 through 246 upstream of the 39 splice site in control animals. The critical A is underlined. No candidate BPS sequences
are present in this vicinity in the narcolepsy-associated intron. In transcripts from narcoleptic Labrador retrievers, exon 5 is spliced directly
to exon 7, omitting exon 6 (narc. Lab. versus wild type). Genomic DNA analysis revealed a G to A transition in the 59 splice site consensus
sequence (shown in red).
proper membrane localization and/or cause loss of func- of this system in the control of feeding (De Lecea et al.,
1998). In support of this hypothesis was the observationtion of this strongly evolutionarily conserved protein.
These mutations are consistent with the observed autoso- that centrally administered hypocretin-1 and -2 stimu-
late appetite in rodents (Sakurai et al., 1998) and thatmal recessive transmission of the disorder in these breeds.
preprohypocretin mRNA is upregulated by fasting (Sa-
kurai et al., 1998). More recent experiments suggest aA Role for Hypocretins in the Pathophysiology
more complex picture. First, the suggested initial colo-of Narcolepsy and the Regulation
calization with MCH was not substantiated by furtherof REM Sleep
studies (Broberger et al., 1998). Second, there is contro-Hypocretins were first identified by De Lecea et al. (1998)
versy regarding the magnitude of the effect of hypo-using a direct tag PCR subtraction technique aimed at
cretins on food consumption in rodents (Lubkin andthe isolation of hypothalamic-specific transcripts. These
Stricker-Krongrad, 1998; Edwards et al., 1999; Ida et al.,authors isolated the preprohypocretin mRNA and showed
1999; Moriguchi et al., 1999; Sweet et al., 1999). Forthat the corresponding precursor protein is likely to be
example, while hypocretins stimulate short-term foodprocessed into two related peptides, hypocretin-1 and -2.
intake, these peptides do not alter 24 hr total food con-Hypocretins are localized in the synaptic vesicle and
sumption (Ida et al., 1999). Some authors have also sug-possess neuroexcitatory effects (De Lecea et al., 1998).
gested that hypocretins exert a shift in the diurnal pat-The existence of hypocretins was independently con-
tern of food intake. The effect on energy metabolismfirmed by Sakurai et al. (1998) using biochemical purifi-
seems to be more pronounced than that on feedingcation and ligand binding to cell lines expressing se-
behavior (Lubkin and Stricker-Krongrad, 1998) and dif-lected orphan G protein±coupled receptors. Two orphan
fers with the circadian time of administration (Ida et al.,receptors were found to bind hypocretin-1 (also called
1999). These two observations may have to be reconsid-orexin-A) and hypocretin-2 (orexin-B) with different af-
ered in the light of potential wake-promoting effects offinity profiles (Sakurai et al., 1998). The first of these
hypocretins. Recent studies suggest complex interac-receptors, now called hypocretin receptor 1 (Hcrtr1),
tions between hypocretins, MCH-containing neurons,was shown to selectively bind hypocretin-1, whereas
neuropeptide Y, agouti gene±related protein systems,Hcrtr2 binds both hypocretin-1 and -2 with a similar
and leptins in the control of feeding and energy balanceaffinity.
(Broberger et al., 1998; Beck and Richy, 1999; HorvathInitially, the finding that preprohypocretin RNA mole-
et al., 1999; Kalra et al., 1999; Marsh et al., 1999; Mori-cules and hypocretin-immunoreactive cell bodies were
guchi et al., 1999; Yamamoto et al., 1999).discretely localized to a subregion of the dorsolateral
Further neuroanatomical work on hypocretins and theirhypothalamus and a hypothesized colocalization of hy-
receptors suggests a broader role than the regulationpocretins with melanin-concentrating hormone (MCH),
a potent orexigeneic peptide, suggested a possible role of energy balance and feeding. Immunocytochemical
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studies have shown that while the preprohypocretin- human and canine subjects with narcolepsy, brain neu-
rotransmitter levels and receptors have been measuredpositive neurons are discretely localized in the periforni-
cal nucleus and in the dorsal and lateral hypothalamic (Miller et al., 1990; Aldrich, 1993). In narcoleptic animals,
the most consistent abnormalities were observed in theareas, their projections are widely distributed through-
out the brain (Peyron et al., 1998; Date et al., 1999; amygdala where significant increases in dopamine and
metabolite levels were reported in two independentMondal et al., 1999; Nambu et al., 1999; van den Pol,
1999). Consistent with the potential role of hypocretins studies (Miller et al., 1990). These results were inter-
preted as suggesting decreased dopamine turnover andin the regulation of feeding, projection sites include in-
trahypothalamic sites such as the arcuate nucleus and accumulation of dopamine in presynaptic terminals. An-
other important finding was the observation of increasedparaventricular nucleus. Other major projection sites,
however, include the cerebral cortex, the spinal cord muscarinic M2 receptors in the pontine reticular forma-
tion (Baker and Dement, 1985; Kilduff et al., 1986), a(dorsal horn), medial nuclei groups of the thalamus, the
olfactory bulb, basal forebrain structures such as the region where cholinergic stimulation triggers REM sleep
in normal animals. The functional significance of thesediagonal band of Brocca and the septum, limbic struc-
tures such as the amygdala and the medial part of the abnormalities has been addressed in experiments where
active pharmacological agents are locally injected oraccumbens nucleus, and brainstem areas including
periaqueductal gray, reticular formation, pedunculopon- perfused in specific brain areas of freely moving narco-
leptic animals. These experiments have shown thattine nucleus, parabrachial nucleus, locus coeruleus, ra-
phe nuclei, subtantia nigra pars compacta, and ventral widespread hypersensitivity to cholinergic stimulation
likely explains abnormal REM sleep tendencies in narco-tegmental area (Peyron et al., 1998; Date et al., 1999;
Nambu et al., 1999; van den Pol, 1999). The neuroana- lepsy (Nishino and Mignot, 1997). Local injection or per-
fusion of cholinergic agonists in the pontine reticulartomical distribution of Hcrtr1 and Hcrtr2 mRNAs was
studied in rats by Trivedi et al. (1998). Of special interest formation or the basal forebrain area triggers REM sleep
and/or REM sleep atonia in narcoleptic and control ca-is the finding that the Hcrtr1 transcript is mostly localized
in the ventromedian hypothalamic nucleus, hippocam- nines (Nishino and Mignot, 1997). In narcoleptic animals,
however, much lower doses can trigger muscle atonia,pal formation, dorsal raphe, and locus coeruleus. In con-
trast Hcrtr2 mRNA molecules are more abundant in the thus suggesting hypersensitivity to cholinergic stimula-
tion. We have also found that dopaminergic autorecep-paraventricular nuclei and in the nucleus accumbens
(Trivedi et al., 1998). Experiments using radioligand binding tor stimulation (D2/D3) in the ventral tegmental area
(VTA) induces cataplexy and sleepiness in narcolepticand immunocytochemical techniques are needed to fur-
ther establish the respective pattern of expression of these but not in control canines (Reid et al., 1996). As this
dopaminergic system and its projection to the nucleusreceptors in relation to hypocretin projection sites.
How could a defect in the Hcrtr2 gene produce narco- accumbens and other limbic structures are involved in
the perception of pleasurable emotions, this could ex-lepsy? There is no direct published evidence suggesting
significant sleep/wake effects for hypocretins. Pharma- plain the triggering of cataplexy by positive emotions
(Reid et al., 1996; Nishino and Mignot, 1997). Narcolepsycological, neurochemical, and physiological studies im-
plicate monoaminergic and cholinergic neurotransmis- may thus result from abnormal interactions between
REM-on cholinergic pathways and mesocorticolimbicsions as the main modulators in narcolepsy (Mignot et
al., 1993b; Nishino and Mignot, 1997). The human sleep dopaminergic systems (Nishino and Mignot, 1997).
The discovery that a mutation in the Hcrtr2 locus pro-disorder is treated using amphetamine-like stimulants
for the control of daytime sleepiness and antidepressant duces canine narcolepsy suggests that hypocretins and
Hcrtr2 are major neuromodulators of sleep in interactiondrugs for the control of abnormal REM sleep manifesta-
tions (e.g., cataplexy). Pharmacological analysis using with aminergic and cholinergic systems. This effect
might be especially important during early development,the canine model has shown that inhibition of dopamine
uptake and/or stimulation of dopamine release mediates since canine narcolepsy typically develops between 4
weeks and 6 months of age and severity increases untilthe wake-promoting effects of amphetamine-like stimu-
lants (Nishino and Mignot, 1997). Other experiments animals are approximately 1 year old (Mignot et al.,
1993a; Riehl et al., 1998). We have also found thathave shown that inhibition of noradrenergic uptake me-
diates the anticataplectic effects of antidepressive ther- canarc-1 heterozygote animals may exhibit brief epi-
sodes of cataplexy when pharmacologically stimulatedapy (Mignot et al., 1993b). The effect on cataplexy paral-
lels the well-established REM suppressant effect of with a combination of cholinergic agonists and drugs
depressing monoaminergic activity but only during earlyadrenergic uptake inhibitors. Stimulation of cholinergic
transmission using acetylcholine esterase inhibitors or development (Mignot et al., 1993a). Projection sites and
reported Hcrtr2 localization are in agreement with a con-direct M2 agonists also stimulates cataplexy (Nishino
and Mignot, 1997). These results suggest that the phar- certed effect of hypocretins, monoamines, and acetyl-
choline on sleep±wake regulation. Hypocretin neuronsmacological control of cataplexy, a symptom resem-
bling REM sleep atonia, is very similar to the control of are known to project to monoaminergic brainstem cell
groups, such as the LC or the VTA, and to the cholino-REM sleep and involves a reciprocal interaction between
pontine cholinergic REM-on cells and aminergic locus ceptive pontine reticular formation and associated cho-
linergic cell groups (Peyron et al., 1998; Date et al., 1999;coeruleus (LC) REM-off cells and their projection sites
(Mignot et al., 1993b; Nishino and Mignot, 1997). Nambu et al., 1999). Other major projection sites, such
as the cortex, the basal forebrain area, the nucleus ac-In order to determine the neuroanatomical basis for
the sleep abnormalities observed in narcolepsy, several cumbens, and the amygdala (Peyron et al., 1998; Date
et al., 1999; Nambu et al., 1999), are also consistent withcomplementary approaches have been taken. In both
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to lie within our relatively large region of interest (GSTA4-PRIM2A)interactions at the level of target projections for these
and to attempt to characterize the relative order of our selected ESTneurotransmitters. Functional experiments aimed at
loci. One microliter of each hybrid DNA, plus positive and negativestudying the effects of hypocretins on sleep after sys-
control parental cell DNA, was transferred for PCR in a 96-well PCR
temic and central (e.g., intracerebroventricular injection plate. PCR primers published in dbSTS (http://www.ncbi.nlm.nih.gov/
and/or local perfusion in selected brain areas) adminis- dbSTS/index.html) or the previously mentioned online sites were
obtained and used in a 10 ml PCR reaction to amplify these genes.tration are now critically needed. We expect that the
Amplification was performed as follows: 958C for 5 min; 35 cyclescentral and peripheral administration of hypocretins will
of 958C for 30 s, 528C±628C (primer dependent) for 30 s, 728C for 30be potently wake promoting and suppress REM sleep
s, and a final extension of 728C for 10 min. The reaction productsvia a stimulation of Hcrtr2 in control but not in narcolep-
were run on a 2% agarose gel and scored for the presence of a
tic animals. human specific PCR product of the expected size. A positive result
The phenotypes of human and canine narcolepsy and was denoted with the number one (1), and negative result a number
two (2), and an ambiguous result was given an R. The data vectorassociated neurochemical abnormalities are strikingly
was submitted to the Stanford Human Genome Center (SHGC) radia-similar (Baker and Dement, 1985; Nishino and Mignot,
tion hybrid server (http://www-shgc.stanford.edu/RH/rhserverform-1997). Abnormalities in the hypocretin neurotransmis-
new.html) in order to perform a two-point analysis with the geneticsion system are thus likely to be also involved in human
markers contained in their database. The most tightly linked RH
cases. Mutations in the HCRTR2 gene or other hypocre- marker and the estimated distance from that marker were returned
tin family genes may be involved in some familial cases by the RH server.
of human narcolepsy, some of which are non-HLA asso-
ciated (Mignot, 1998). The observation that rare cases of Screening of the Canine BAC Library with Human EST Probes
Human IMAGE consortium clones mapping to the pericentromericsymptomatic secondary narcolepsies are most typically
region of human chromosome 6 were identified through scrutiny ofassociated with lesions surrounding the third ventricle
available data from maps constructed by the Whitehead Insti-is also consistent with a destruction of hypocretin-con-
tute for Genomic Research (http://carbon.wi.mit.edu:8000/cgi-taining cell groups (Aldrich and Naylor, 1989). As most
bin/contig/phys_map), GeneMap 96 (http://wwwncbi.nlm.nih.gov/
cases of human narcolepsy are nonfamilial and strongly SCIENCE96/), GeneMap 98 (http://www.ncbi.nlm.nih.gov/gene
HLA associated (Mignot, 1998), an autoimmune process map98), the Sanger Centre (http://www.sanger.ac.uk/HGP/Rhmap/
maps.shtml), the Stanford Human Genome Center (http://www-directed against the Hcrtr2 or the very localized paraven-
shgc.stanford.edu/RH/rhserverformnew.html), and through Unigenetricular hypothalmic nucleus, or more complex neuroim-
(http://www.ncbi.nlm.nih.gov/UniGene/Home.html). Selected clonesmune interactions may also be involved in the patho-
were obtained from Research Genetics (Huntsville, AL) and verifiedphysiology of human narcolepsy.
through sequence analysis of extracted DNA. IMAGE clone inserts
Finally, hypocretins or analogs may offer new thera- were excised and band-purified on agarose gels (Qiaquick spin
peutic avenues in narcolepsy and other sleep disorders. columns, Qiagen) for use as hybridization probes. Probes were eval-
uated by hybridization of strips of Southern-blotted canine genomicHypocretin-1 has been shown to enter the brain after
DNA. Those not producing high background signal or obvious non-peripheral administration (Kastin and Akerstrom, 1999).
specific hybridization signals were used to screen the Canine Geno-A reduction of Hcrtr2-mediated neurotransmission might
mic BAC library. Hybridizations and washes were performed in stan-be supplemented in some cases by increasing ligand
dard BAC library buffers as described in Li et al. (1999) but were
availability. carried out at 518C±538C to reduce stringency. Positive clones were
selected from the library, streaked onto LB plates supplemented
with chloramphenicol, and DNA was extracted from 5 ml minicul-Experimental Procedures
tures of single clones. BAC DNA was digested with EcoRI and SacI,
electrophoresed in agarose gels, and Southern blotted onto nylonCanine Subjects and Genetic Linkage Analysis
filters. Filters were hybridized with the appropriate EST probes toBackcross narcoleptic Dobermans and Labradors were produced
identify true positive clones. Positive clones were grouped into binsin our breeding colony at the Center for Narcolepsy as described
based on patterns produced by ethidium bromide staining and hy-in Cederberg et al. (1998). The procedure to determine phenotypic
bridization results. Clones from each bin were further characterizedstatus for these dogs is described in Mignot et al. (1993a). All experi-
through two-color chromosomal FISH using a previously character-mental procedures were done in accordance with the NIH guidelines
ized CFA12 BAC (as described in Li et al., 1999) clone as a positivefor laboratory animal care. Two familial cases of canine narcolepsy
control to verify that the clones were in the narcolepsy region. Inwere reported to our attention for therapeutic advice by a veterinar-
most cases, plasmid minilibrary clones were also hybridized withian and a breeder, respectively (see text). Diagnosis for these cases
the EST probes, and resulting subclones were sequenced in orderwas verified by phone interview and breeding into the colony when-
to identify homologous canine exon sequences.ever possible (one of two cases). Linkage analysis was performed
as described in Mignot et al. (1991), with kind assistance of Neil
Risch (Stanford, CA). Canine Fluorescence In Situ Hybridization
BAC clones were analyzed by FISH on canine metaphase spreads
to confirm location on CFA12. Briefly, BAC clones were labeled withRadiation Hybrid Mapping of EST Candidate Loci and Human
EST Clone Selection digoxygenin or biotin conjugated nucleotides using nick translation
kits (Boehringer Mannheim and GIBCO±BRL). Following nick trans-At the time our project started, EST mapping information obtained
from various online sources, such as Genemap '96 (http:// lation, 100±500 ng of labeled DNA was twice precipitated together
with 10 mg of sheared total dog genomic DNA and 1 mg of salmonwww.ncbi.nlm.nih.gov/SCIENCE96/), Whitehead Institute (http://
carbon.wi.mit.edu:8000/cgi-bin/contig/phys_map), and Sanger Center sperm DNA. After resuspension with 10 ml of formamide hybridiza-
tion buffer, DNAs were denatured for 10 min at 708C, directly trans-(http://www.sanger.ac.uk/HGP/Rhmap/maps.html), was often con-
tradictory or of a low resolution, so that the precise location of these ferred to 378C, and allowed to preanneal for at least 15 min. Canine
metaphase chromosome spreads were prepared from peripheralgenes was not reliably known. Radiation hybrid (RH) mapping is a
simple and reliable method for mapping genes (Cox et al., 1990), lymphocytes according to standard methods (Barch, 1997). Prior
to hybridization, chromosome slides were treated with RNase andand whole genome RH panels have been developed to quickly local-
ize genes to their unique chromosomal location. We made use of subjected to dehydration in an ethanol series (70%, 80%, 90%,
100%) for 5 min in each concentration, and allowed to air dry. Thethe 83 hybrid Stanford G3 radiation hybrid panel to map a number
of candidate anchor ESTs in order to verify that the EST was likely chromosome spreads were next denatured in 70% formamide, 23
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SSC at 658C for 5 min, quenched in iced 70% ethanol, and again microsatellite repeat markers in the region. These markers were
used to test all BAC clones. BAC clone insert sizes are determineddehydrated in an ethanol series. After air drying, slides were hybrid-
ized to labeled BACs at 378C overnight. Some BAC clones were using NotI digestion followed by pulsed field gel electrophoresis in
1% agarose with a CHEF-DRII system (BioRad) as described in Lianalyzed by sequential G-banding-FISH to allow specific chromo-
somal assignments. GTW-banded slides were photographed and et al. (1999). STSs for which location was not strictly constrained
were spaced at roughly equidistant intervals between constraineddestained by three 1 min washes in 3:1 methanol/acetic acid. Slides
were then dried and treated in 23 SSC at 378C for 30 min and then markers. To verify clone integrity, fingerprinting was performed on
all clones using EcoRV, HindIII, and BglII. Fragment sizes were esti-dehydrated in an ethanol series. Thirty microliters of probe mix was
added and sealed under a 24 3 50 mm coverslip. Chromosomal mated after ethidium bromide staining using established molecular
weight markers and the Biorad 200 imaging system. Contig assem-and target DNAs were denatured together by incubating on a slide
warmer at 658C for 30 s, and then transferred to 378C overnight for bly was performed manually with assistance of the contig ordering
package (Whitehead Institute) and Segmap for STS mapping (Greenhybridization. Following hybridization, slides were washed at 458C
for 20 min in 50% formamide/23 SSC, two times for 10 min each and Green, 1991) and FingerPrint contig (http://www.sanger.ac.uk/
Users/cari/fpc.shtml) for fingerprinting (Soderlund et al., 1997).in 13 SSC, and two times for 10 min each in 0.53 SSC. Slides were
then blocked for 15 min at 378C with 43 SSC/3% BSA, and signals
were detected with Rhodamine-coupled sheep anti-digoxigenin RT±PCR Amplification and Sequencing of the Hcrtr2 cDNA
FAB fragments (Boehringer Mannheim) or avidin-fluorescein DCS in Control and Narcoleptic Canines
(Vector Labs). Following detection, slides were washed three times Total RNA extraction and mRNA purification from wild-type (four
in 43 SSC/0.1% Triton X100 for 5 min each and mounted/counter- Dobermans, two Labradors) and narcoleptic (four Dobermans, two
stained with Vectashield containing Dapi and/or propidium iodide Labradors) dog brain were performed using the RNeasy Maxi (Qia-
(Vector Labs) and viewed on a Nikon Axioskop microscope with gen) and Oligotex mRNA Midi Kits (Qiagen), respectively. We gener-
epifluorescence. ated first-strand cDNA using mRNA (1 mg), AMV reverse tran-
scriptase (SuperScript II RT; 200 U; GIBCO±BRL), and E. coli RNaseH
(2 U) according to the manufacturer's recommendation. PCR prim-Chromosome Walking Using Canine BAC End Probes
ers and conditions for RT±PCR amplification are described in theThe development of a high-density BAC contig map was primarily
Figure 5 legend.based on chromosome walking and PCR assay results. The BAC
clones were obtained through library screening by hybridization and
verified through PCR of derived sequence tag site (STS) markers. PCR Amplification of the canarc-1 SINE Insertion
For the purposes of contig extension, the outlying STS-PCR prod- Genomic DNA was amplified with PCR primers flanking the SINE
ucts from each side of the contig were selected for hybridization of insertion using w554-65seqF 5(9GGGAGGAACAGAAGGAGAGAATT
the high-density gridded filters of the library as described in Li et T39) and R4/7-6R(110) (59ATAGTTGTTAATGTGTACTTTAAGGC39).
al. (1999). STS markers were designed to each end of each BAC PCR conditions were 958C for 2 min; 30 cycles of 948C for 1 min,
clone. BAC end sequences were first analyzed with BLAST to iden- 558C for 1 min, and 728C for 1 min.
tify common dog repetitive elements. PCR primers for STS markers
were designed in regions of unique sequence using the Primer3 PCR Amplification and Sequencing of Exon 6±Intron 6
program (http://www.genome.wi.mit.edu/cgi-bin/primer/primer3.cgi). Boundary for Identification of the Labrador
Amplification was performed as follows: 958C for 5 min, 25 cycles canarc-1 Mutation
of 948C for 1 min, 558C±608C (primer dependent) for 1 min, 728C for Genomic DNA was amplified with PCR primers flanking exon 6 and
1 min, and a final extension of 728C for 10 min. PCR products were intron 6 using 6INF(162) (59GACTTCATTTGGCCTTTGATTTAC39)
analyzed on 1.5% agarose gels followed by staining in ethidium and 7EXR(1620) (59TTTTGATACGTTGTCGAAATTGCT39). PCR con-
bromide solution. ditions were 948C for 2 min; five cycles of 948C for 1 min, 588C for
1 min, 728C for 1 min; 30 cycles of 948C for 1 min, 558C for 1 min, 728C
for 1 min, and a final extension of 728C for 5 min. Cycle sequencing onPolymorphic Marker Isolation and Genetic Typing in Canine
the PCR product was performed using the 6INF(162) primer, andClones and Genomic BAC Clones
reactions were analyzed on an ABI 377 DNA sequencer.Microsatellite markers were isolated using minilibraries constructed
from selected genomic BAC clones. Briefly, BAC clones were triple
digested with DraI, SspI, and EcoRV (Amersham), and the resulting Bioinformatics
digests were ligated to pBluescript, transformed, and plated on LB/ Sequence contig and sequence comparisons were performed using
Agar plates covered with a Duralose-UV (Stratagene) membrane. the Sequencher 3.0 program (Gene Codes). cDNA-genomic DNA
Following overnight growth in a 378C incubator, replica filters were comparisons were performed using the BLAST program (http://
made using a second duralose membrane, applying pressure, and www.ncbi.nlm.nih.gov/cgi-bin/BLAST/nph-newblast). Genemap 1996
marking by puncture. Replica filters were transferred to LB/Agar (The Human Transcript Map) and Genemap 1998 can be found at
plates, allowed to grow, and then colonies were lysed in situ by http://wwwncbi.nlm.nih.gov/SCIENCE96/ and http://www.ncbi.nlm.
alkaline lysis as follows. Membranes were placed on Whatman paper nih.gov/genemap98, respectively. The Sanger Center Human Chro-
wet with 10% SDS for 5 min, and then transferred to denaturing mosome Radiation Hybrid Maps can be found at http://www.sanger.
and neutralizing solutions for 5 min each. DNA was then cross- ac.uk/HGP/Rhmap/maps.html. The Stanford Human Genome Cen-
linked using UV light and washed in 23 SSPE/1% SDS. Next, the ter RHServer submission form can be found at http://www-
membranes were hybridized with [g-32P]dATP radiolabeled (CA)15, shgc.stanford.edu/RH/rhserverformnew.html. The Whitehead phys-
(GAAA)8, (GAAT)8, and/or (GATA)8 oligonucleotides and washed ical mapping project can be found at http://carbon.wi.mit.edu:8000/
in 0.13 SSPE/0.1% SDS or 13 SSPE/0.1% SDS (658C or 558C, cgi-bin/contig/phys_map. The FPC (Software for FingerPrinting
respectively, for dinucleotide versus tetranucleotide probes). Plas- Contigs) can be found at http://www.sanger.ac.uk/Users/cari/
mid DNAs were extracted from all positive colonies (Qiagen) and fpc.shtml. The human gene mutation database (Institute of Medical
sequenced on an ABI 377 DNA sequencer using T3 and T7 primers. Genetics, Cardiff) can be found at http://www.uwcm.ac.uk/awcm/
The program Primer3 was used to design flanking primers on all mg/hgmd0.html.
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